$266 Million is the total value of Blue Water Life Science Advisors, LP's 22 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 80.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HTGM | Sell | HTG MOLECULAR DIAGNOSTICS IN | $841,000 | +124.3% | 144,881 | -2.8% | 0.32% | +72.7% |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -20,938 | -100.0% | -1.30% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -163,977 | -100.0% | -4.02% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -251,695 | -100.0% | -4.95% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -166,957 | -100.0% | -10.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NATERA INC | 12 | Q3 2023 | 33.3% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 21.3% |
| AKOYA BIOSCIENCES INC | 8 | Q3 2023 | 23.4% |
| ADAPTIVE BIOTECHNOLOGIES COR | 8 | Q3 2023 | 17.7% |
| CAREDX INC | 7 | Q2 2022 | 19.0% |
| THERMO FISHER SCIENTIFIC INC | 5 | Q4 2021 | 16.0% |
| MAXCYTE INC | 5 | Q3 2023 | 11.8% |
| BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
| SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
| CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-18 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.